"CD44 is a nexus between prognosis and therapeutics for brain cancer ..."

Linhan Cai et al. (2025)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOMED.2025.109869

access: closed

type: Journal Article

metadata version: 2025-04-21

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cbm/CaiLCD25
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/CaiLCD25
Linhan Cai, Xinyu Lv, Yiming Chen, Xiaofeng Dai:
CD44 is a nexus between prognosis and therapeutics for brain cancer management. Comput. Biol. Medicine 189: 109869 (2025)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.